Arf GTPase Regulation in Cancer Cell Migration

Arf GTPases are pivotal molecular switches that coordinate membrane trafficking and cytoskeletal dynamics to drive cancer cell movement. Cycling between an inactive GDP-bound state and an active GTP-bound state, Arf proteins such as Arf6 orchestrate the assembly and disassembly of adhesions, invadopodia and lamellipodia. Activation is mediated by guanine nucleotide exchange factors (GEFs) that promote GTP loading, whereas GTPase-activating proteins (GAPs) accelerate GTP hydrolysis to terminate signalling. Through interactions with scaffold proteins and lipid second messengers, Arf6 integrates signals from receptor tyrosine kinases and G-protein-coupled receptors to regulate Rho family GTPases and direct protrusive forces. Dysregulation of this cycle enhances invasive behaviour, fosters epithelial–mesenchymal transition and contributes to metastasis. Ongoing research unravels novel effectors and regulatory complexes, revealing potential targets for therapeutics aimed at curbing cancer cell dissemination.

Research from Nature Portfolio

Recent studies have delineated critical nodes in Arf6-driven motility. A 2023 investigation demonstrated that the scaffold protein CNK2 links the pro-metastatic receptor AXL to cytohesin GEFs and a novel adaptor, SAMD12, thereby activating Arf6 at the plasma membrane. This axis coordinates reciprocal regulation of RAC1 and RHOA to control invadopodial dynamics and invasive force generation, with genetic ablation of CNK2 or SAMD12 markedly reducing metastasis in vivo. Foundational work has also shown that lysophosphatidic acid engages a GPCR-EFA6 pathway to activate Arf6 in renal carcinoma, driving mesenchymal properties and invasive behaviour. Earlier research into hepatocyte growth factor signalling revealed that Arf6-dependent β1 integrin recycling underlies endothelial migration and tumour neoangiogenesis, underscoring the breadth of Arf6 roles in both cancer cells and the tumour microenvironment.

Arf GTPase Regulation in Cancer Cell Migration publication trend

The graph below shows the total number of articles in arf gtpase regulation in cancer cell migration across all publications each year (not limited to Nature Index journals).

Technical terms

Arf GTPase: A small GTP-binding protein that regulates membrane trafficking and actin remodelling by cycling between GDP- and GTP-bound forms.

Guanine nucleotide exchange factor (GEF): A protein that catalyses the exchange of GDP for GTP to activate small GTPases.

GTPase-activating protein (GAP): A protein that accelerates GTP hydrolysis on small GTPases, returning them to an inactive state.

Invadopodia: Actin-rich protrusions specialised for extracellular matrix degradation and invasive migration.

Focal adhesions: Multiprotein complexes that link the actin cytoskeleton to the extracellular matrix, mediating cell attachment and signalling.

Epithelial–mesenchymal transition (EMT): A cellular programme by which epithelial cells acquire mesenchymal features, enhancing motility and invasiveness.

References

1. CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling. Nature Communications (2023).
2. Lysophosphatidic acid activates Arf6 to promote the mesenchymal malignancy of renal cancer. Nature Communications (2016).
3. Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial β1 integrin recycling. Nature Communications (2015).
4. ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. Cell Death & Disease (2023).
5. New targets and designed inhibitors of ASAP Arf-GAPs derived from structural characterization of the ASAP1/440-kD ankyrin-B interaction. Journal of Biological Chemistry (2024).
6. The Role of ARF Family Proteins and Their Regulators and Effectors in Cancer Progression: A Therapeutic Perspective. Frontiers in Cell and Developmental Biology (2020).